Main menu links
Montagu Private Equity completes its first investment in Central Europe
For more information please contact:
Michał ChałaczkiewiczDirector
T: +44 20 7336 9988
E: michal.chalaczkiewicz@ montagu.com
More information about Michał Chałaczkiewicz
Montagu Private Equity (“Montagu”), one of Europe’s leading private
equity companies is pleased to announce its first investment in
Central and Eastern Europe (“CEE”) with an equity investment in
Euromedic International (“Euromedic”). Montagu is co-investing €70m
alongside Merrill Lynch Global Private Equity, Ares Life Sciences
and the existing management team.
Euromedic was founded in 1991 and is the largest Pan-European operator of healthcare services such as diagnostic imaging, renal care and dialysis, and clinical laboratory services. Based in Hungary Euromedic has operations across 15 countries in both CEE (Poland, Czech Rep., Hungary, Russia, Romania, Croatia, Bosnia & Herz. and Bulgaria) and Western European markets. In total it operates 170 centres and has 4,800 employees including more than 1,000 medical doctors.
As a leading player in a growing market, the business has a strong track record of profitable growth and is well positioned to benefit from the increasing demand for healthcare services across Europe and the trend towards more privatised and decentralised healthcare provision. This will be achieved through a combination of growth of existing centres as well as new centres opening and further consolidation of the market.
Commenting on the acquisition, Michal Chalaczkiewicz, Montagu’s Investment Director responsible for the CEE area said: “We are delighted that Euromedic is our first investment in the CEE region. It is a high quality business led by an exceptional management team both at the Group and country levels. This business fits perfectly with Montagu’s key deal characteristics, which we will be looking to replicate in future investments in the CEE area. We are excited about working with the current management team and employees, and investing in Euromedic’s next phase of growth”.
Joseph Priel, CEO of Euromedic said: “We welcome the investment of Montagu. Their past record and CEE expertise will help the company to further develop its business".
Euromedic was founded in 1991 and is the largest Pan-European operator of healthcare services such as diagnostic imaging, renal care and dialysis, and clinical laboratory services. Based in Hungary Euromedic has operations across 15 countries in both CEE (Poland, Czech Rep., Hungary, Russia, Romania, Croatia, Bosnia & Herz. and Bulgaria) and Western European markets. In total it operates 170 centres and has 4,800 employees including more than 1,000 medical doctors.
As a leading player in a growing market, the business has a strong track record of profitable growth and is well positioned to benefit from the increasing demand for healthcare services across Europe and the trend towards more privatised and decentralised healthcare provision. This will be achieved through a combination of growth of existing centres as well as new centres opening and further consolidation of the market.
Commenting on the acquisition, Michal Chalaczkiewicz, Montagu’s Investment Director responsible for the CEE area said: “We are delighted that Euromedic is our first investment in the CEE region. It is a high quality business led by an exceptional management team both at the Group and country levels. This business fits perfectly with Montagu’s key deal characteristics, which we will be looking to replicate in future investments in the CEE area. We are excited about working with the current management team and employees, and investing in Euromedic’s next phase of growth”.
Joseph Priel, CEO of Euromedic said: “We welcome the investment of Montagu. Their past record and CEE expertise will help the company to further develop its business".